DR. DOPING

Instructions

Logo DR. DOPING

Instructions / Instruction for use: Loram

I want this, give me price

Dosage form: tablets

Active substance: Lorazepam*

ATX

N05BA06 Lorazepam

Pharmacological group:

Anxiolytics

The nosological classification (ICD-10)

F20 Schizophrenia: Schizophrenic conditions; Exacerbation of schizophrenia; Schizophrenia; Chronic schizophrenia; Dementia praecox; Bleuler's disease; Psychotic discordant; Dementia early; The febrile form of schizophrenia; Chronic schizophrenic disorder; Psychosis of the schizophrenic type; Acute form of schizophrenia; Acute schizophrenic disorder; Cerebral Organic Insufficiency in Schizophrenia; Acute attack of schizophrenia; Schizophrenic psychosis; Acute schizophrenia; Sluggish schizophrenia; Sluggish schizophrenia with apathoabulic disorders; Acute stage of schizophrenia with excitation

F40 Phobic anxiety disorders: A state of fear; Fear; Phobia; Phobic disorders; Phobias; Anxiety neurosis; Anxiety of anxiety; Obsessive fears; Acute anxiety disorder; Paroxysmal fear syndrome; Feeling of fear; Night Fears

F41 Other anxiety disorders: Anxiety status; Anxiety; Chronic alarm; Sense of anxiety; Anxious-hypothetical states; Stopping an alarm; Nonpsychotic anxiety disorders

F48 Other neurotic disorders: Neurosis; Neurological diseases; Neurotic disorders; Neurotic condition; Psychoneurosis; Anxious-Neurotic Conditions; Chronic neurotic disorders; Emotional reactive disorders

F91 Behavioral disorders: Juvenile and other behavioral disorders; Destructive behavior; Violation of behavior; Behavioral disorders; Mixed behavioral disorders; Behavioral Disorder; Behavioral disorder in adolescents with 15 years of age and adults; Violations in behavior; Behavioral disorders in childhood; Behavioral disorders in old age; Behavioral disorders in children; Behavior Disorder; Behavioral disorders in children

G47.0 Disorders of falling asleep and maintaining sleep [insomnia]: Insomnia; Insomnia, especially difficulty falling asleep; desynchronosis; Prolonged sleep disturbance; Difficulty falling asleep; Short-term and transient insomnia; Short-term and chronic sleep disorders; Short or shallow sleep; Violation of sleep; Disturbed sleep, especially in the phase of falling asleep; Infringements sleep; sleep disturbances; Neurotic sleep disturbance; Shallow superficial sleep; shallow sleep; Poor quality of sleep; Night awakening; sleep Pathology; Postsomnic violation; transient insomnia; Trouble falling asleep; Early awakening; Early morning awakening; Early awakening; sleep disorder; somnipathy; persistent insomnia; difficult to fall asleep; difficulty falling asleep; Difficulty falling asleep in children; persistent insomnia; Worsening sleep; Chronic insomnia; Frequent night and / or early morning awakening; Frequent nocturnal awakening and a sense of the depth of the non-sleep; Night waking

Composition and release form

1 tablet contains lorazepam 1 or 2.5 mg; in a blister of 15 and 10 pcs. respectively, in the package 2 blisters.

Pharmachologic effect

Mode of action - anxiolytic, sedative.

Excites benzodiazepine receptors of the central nervous system and increases the effectiveness of GABAergic transmission, reduces mental stress, stabilizes the autonomic nervous system.

Indication of the drug Loram

Psychoneurosis (anxiety neurosis, coercive neurosis, phobia), mental stress with a sense of fear, anxiety, danger and insolvency; Behavioral disorders, anxiety in depression and schizophrenia; fear and psychosomatic disorders in cardiovascular, respiratory, gastrointestinal and other organic diseases, insomnia.

Contraindications

Myasthenia gravis.

Application in pregnancy and breastfeeding

Allowed under strict medical supervision.

Side effects

Drowsiness, dizziness, fatigue, dry mouth, muscle weakness, ataxia, visual disorders.

Dosing and Administration

Inside, for outpatients - 1-3 mg per day, for psychiatric patients - 3-7.5 mg per day. When insomnia - 1 mg at night.

Precautionary measures

It requires special attention and careful dose selection for older patients, with reduced body weight, cerebral sclerosis, heart failure, hypotension. During treatment, you should not drink alcohol within 4 hours after taking, it is not recommended to drive or use equipment that requires intense attention. Avoid sudden discontinuation of treatment (a gradual dose reduction according to the scheme is required).

Storage conditions of the drug Loram

Keep out of the reach of children.

Shelf life of the drug Loram

2 years.

Do not use after the expiry date printed on the package.

Someone from the Italy - just purchased the goods:
Tanakan 40mg 30 pills